Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Clinical evidence remains limited and outcomes vary by patient
The REMAIN-1 Pivotal Cohort has completed enrollment, and the Company remains on track to randomize patients in early 2026 and deliver 6-month topline primary endpoint data and potentially file a PMA in H2 2026
Methods Plasmid and strain construction Standard molecular biology techniques were used to construct strains (Supplementary Table 1) and plasmids (Supplementary Table 2)
States Building the Most Homes in the Fire Line As housing spreads into the fire line, exposure is rising sharply, compounding loss potential and challenging long-term insurability
US$ 28.11
US$ 29.49
US$ 23.16
US$ 29.82
US$ 25.14
